OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1582-1582
Open Access | Times Cited: 11
Shunzhen Zheng, Siew Wee Chan, Fei Liu, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1582-1582
Open Access | Times Cited: 11
Showing 11 citing articles:
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 6
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 6
c-FLIP/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma
Yasamin Haghir-Sharif-Zamini, Arezoo Khosravi, Moustapha Hassan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110306-110306
Closed Access
Yasamin Haghir-Sharif-Zamini, Arezoo Khosravi, Moustapha Hassan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110306-110306
Closed Access
Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
Jiarui Lv, Yanan Wang, Jiacheng Lv, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Jiarui Lv, Yanan Wang, Jiacheng Lv, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Dihydroartemisinin suppresses COX-2-mediated apoptosis resistance in hepatocellular carcinoma under endoplasmic reticulum stress
Lulu Cao, Jun Lin, Yun Fang, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Lulu Cao, Jun Lin, Yun Fang, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation
Nicholas Dale D. Talubo, Estela Máris Amorim Cruz, Peter Matthew Paul Fowler, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 903-903
Open Access
Nicholas Dale D. Talubo, Estela Máris Amorim Cruz, Peter Matthew Paul Fowler, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 903-903
Open Access
Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
Toru Ishikawa, Ryo Sato, Ryo Jimbo, et al.
In Vivo (2024) Vol. 38, Iss. 5, pp. 2501-2505
Open Access | Times Cited: 1
Toru Ishikawa, Ryo Sato, Ryo Jimbo, et al.
In Vivo (2024) Vol. 38, Iss. 5, pp. 2501-2505
Open Access | Times Cited: 1
Identification of Hub Genes and CDK1-Targeting Therapeutics in Hepatocellular Carcinoma: Bioinformatics and Simulation Study
R. Romero, Cláudio Fabiano Motta Toledo
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
R. Romero, Cláudio Fabiano Motta Toledo
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study
Yiwen Hu, Linlin Zhang, Qinghua Qi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Yiwen Hu, Linlin Zhang, Qinghua Qi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Sumit Roy, Vancha Harish, Sharfuddin Mohd, et al.
Advanced Therapeutics (2024)
Closed Access
Sumit Roy, Vancha Harish, Sharfuddin Mohd, et al.
Advanced Therapeutics (2024)
Closed Access
Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells
Jiao Qu, Yueqin Zhang, Cong Song, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jiao Qu, Yueqin Zhang, Cong Song, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Targeted nanoparticle delivery unleashes synergistic photothermal and immunotherapeutic effects against hepatocellular carcinoma
A. Chandra Babu, Padmanaban Sathiyamoorthy, Sahil Chahal, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
A. Chandra Babu, Padmanaban Sathiyamoorthy, Sahil Chahal, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
